Pipeline Analysis for Malaria Therapeutic Development, H2 2016
Summary
Malaria is a life-threatening blood disease caused by a parasite that is transmitted to humans after the bit of an infected female Anopheles mosquito.Following are some of the prime pharmaceutical drugs used by emerging players to prevent malaria- Atovaquone proguanil Doxycycline Mefloquine Chloroquine Primaquine Browse Full Info with TOC: http://www.marketresearchhub.com/report/malaria-pipeline-review-h2-2016-report.html The Malaria pipeline guide also reviews the key players involved in therapeutic development for malaria and features inactive and discontinued projects.MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.Contact Us 90 State Street Albany, NY 12207 United States Toll Free : 866-997-4948 (US-Canada) Tel : +1-518-621-2074 Email : press@marketresearchhub.com Website : http://www.marketresearchhub.com Albany, NY, November 24, 2016 --( PR.com )-- A latest pharmaceutical and healthcare disease pipeline guide by Global Markets Direct has been launched and added to the vast archive of Market Research Hub (MRH).The guide also covers the pipeline products that are based on numerous stages of development ranging from pre-registration till discovery and undisclosed stages.Following are some of the prime pharmaceutical drugs used by emerging players to prevent malaria-Atovaquone proguanilDoxycyclineMefloquineChloroquinePrimaquineBrowse Full Info with TOC: http://www.marketresearchhub.com/report/malaria-pipeline-review-h2-2016-report.htmlThe Malaria pipeline guide also reviews the key players involved in therapeutic development for malaria and features inactive and discontinued projects.